We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





New Biosensor Detects COVID-19 Virus in Air

By HospiMedica International staff writers
Posted on 25 Apr 2020
A team of researchers from Switzerland has succeeded in developing a novel sensor for detecting the new coronavirus that could be used to measure the concentration of the virus in the environment, such as in places where there are many people or in hospital ventilation systems.

The researchers from Empa (Zürich, Switzerland) and ETH Zurich (Zürich, Switzerland) usually work on measuring, analyzing and reducing airborne pollutants such as aerosols and artificially produced nanoparticles. More...
However, the COVID-19 challenge being faced by the whole world made the team shift its focus to developing a sensor that can quickly and reliably detect SARS-CoV-2 - the new coronavirus. Even before the COVID-19 began to spread, the team was researching sensors that could detect bacteria and viruses in the air and in early January, it came up with the idea of using this basis to further develop the sensor in such a way that it could reliably identify a specific virus was born. The sensor would not necessarily replace the established laboratory tests, but could be used as an alternative method for clinical diagnosis, and more prominently to measure the virus concentration in the air in real time, such as in busy places like train stations or hospitals.

As opposed to the molecular method called reverse transcription polymerase chain reaction, or RT-PCR for short, used in labs to detect viruses in respiratory infections, the researchers have developed an alternative test method in the form of an optical biosensor. The sensor combines two different effects to detect the virus safely and reliably: an optical and a thermal one. The sensor is based on tiny structures of gold, so-called gold nanoislands, on a glass substrate. Artificially produced DNA receptors that match specific RNA sequences of the SARS-CoV-2 are grafted onto the nanoislands. The receptors on the sensor are the complementary sequences to the virus' unique RNA sequences, which can reliably identify the virus.

To demonstrate how reliably the new sensor detects the current COVID-19 virus, the researchers tested it with a very closely related virus: SARS-CoV which broke out in 2003 and triggered the SARS pandemic. The validation was successful although a number of developmental steps are still needed to enable the sensor to measure the coronavirus concentration in the air.

“Tests showed that the sensor can clearly distinguish between the very similar RNA sequences of the two viruses,” said Jing Wang, one of the researchers. “This still needs development work. But once the sensor is ready, the principle could be applied to other viruses and help to detect and stop epidemics at an early stage.”

Related Links:
Empa
ETH Zurich



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Trocar
TAN RoTaLock Trocar
New
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.